Anti-MuSK antibody positive myasthenia gravis with HIV infection successfully treated with cyclosporin: A case report

Clinical Neurology

Volumn 48, Issue 9, 2008, Pages 666-669

  Kurokawa, Takashi ^a   Nishiyama, Takehiko ^a   Yamamoto, Ryoo ^a   Kishida, Hitaru ^a   Hakii, Yasuhito ^a   Kuroiwa, Yoshiyuki ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Anti muscle specific tyrosine kinase antibody; Cyclosporine; Human immunodeficiency virus; Myasthenia gravis

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; CYCLOSPORIN; EDROPHONIUM; MUSCLE SPECIFIC TYROSINE KINASE ANTIBODY; PREDNISOLONE; PROTEIN ANTIBODY; PYRIDOSTIGMINE; UNCLASSIFIED DRUG; VIRUS RNA; AUTOANTIBODY; CHOLINERGIC RECEPTOR; IMMUNOSUPPRESSIVE AGENT; MUSK PROTEIN, HUMAN; PROTEIN TYROSINE KINASE;

ADULT; ARTICLE; BULBAR PARALYSIS; CASE REPORT; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DYSPHAGIA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MUSCLE ACTION POTENTIAL; MUSCLE EXCITATION; MYASTHENIA GRAVIS; NEUROLOGIC EXAMINATION; PTOSIS; RELAPSE; REMISSION; THORAX RADIOGRAPHY; THRUSH; BLOOD; IMMUNOLOGY; MIDDLE AGED; TREATMENT OUTCOME;

AUTOANTIBODIES; CYCLOSPORINE; HIV INFECTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CHOLINERGIC; TREATMENT OUTCOME;

EID: 58949100168     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: 10.5692/clinicalneurol.48.666     Document Type: Article

References (5)

1. Towers GJ, Hatziioannou T, Cowan S, et al: Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors. Nat Med 2003; 9: 1138-1143 (Pubitemid 37173697)
2. Cullen BR: HIV-1 infection: fooling the gatekeeper. Nat Med 2003; 9: 1112-1113
3. Tsujimura S, Saito K, Nakayamada S, et al: Clinical relevance of the expression of p-glycoprotein on peripheral blood lymphocytes to steroid resistance in patients with systemic lupus erythematosus. Arthritis Rheum 2005; 52: 1676-1683 (Pubitemid 40852875)
4. Rechard-Patin Y, Vega Boada F, Vidaller A, et al: Multidrug resistance-1 (MDR-1) in autoimmune disorders IV. P-glycoprotein overfunction in lymphocytes from myasthenia gravis patients. Biomed Pharmacother 2004; 58: 320-324
5. Chandler B, Almond L, Ford J, et al: The effects of protease inhibitors and nonnucleoside reverse transcriptase inhibitors on p-glycoprotein expression in peripheral blood mononuclear cells in vitro. J Acquir Immune Defic Syndr 2003; 33: 551-556 (Pubitemid 36975841)